Literature DB >> 11943419

Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality.

Xiangnong Li1, Irving S Benjamin, Barry Alexander.   

Abstract

BACKGROUND/AIMS: Hepatotoxin-induced rat models of liver cirrhosis are limited by the wide heterogeneity of cirrhosis produced. The present study developed a modified, reliable, and reproducible technique by which hepatic and systemic responses to thioacetamide during induction of cirrhosis were monitored by weekly weight changes.
METHODS: Male Wistar rats (200-230 g) were divided into three groups. Group 1 (n=20) received continuous administration of 0.03% (w/v) thioacetamide in the drinking water for 12 weeks. Group 2 (n=20) received the same concentration of 0.03% thioacetamide as an initial concentration that was modified according to weekly weight changes in response to thioacetamide during the induction of cirrhosis. Group 3 (n=6) received normal water and served as controls.
RESULTS: Mortality of Group 1 was 30% and the production of cirrhosis was only 45%. In contrast, there were no deaths in Group 2 and well-developed macronodular cirrhosis was found in 90% of the rats which was associated with significant portal hypertension, as indicated by increased portal venous pressure (13.6+/-0.4 vs. 9.1+/-0.3 mmHg, cirrhotic vs. control, respectively, P<0.01, Student's unpaired t-test).
CONCLUSIONS: Variations in responses to thioacetamide can be easily monitored by weekly weight changes to reduce mortality to zero and simultaneously increase the production and quality of cirrhosis induced in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943419     DOI: 10.1016/s0168-8278(02)00011-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis.

Authors:  Vyacheslav U Buko; Oxana Y Lukivskaya; Elena E Naruta; Elena B Belonovskaya; Horst-Dietmar Tauschel
Journal:  J Clin Exp Hepatol       Date:  2014-02-21

3.  Hepato-cardiovascular response and its regulation.

Authors:  Xiang-Nong Li; Irving S Benjamin; Barry Alexander
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

Review 4.  Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

Review 5.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

6.  The role of nitric oxide in the expression of renal aquaporin 2 in a cirrhotic rat model: does an AVP-independent mechanism exist for the regulation of AQP2 expression?

Authors:  Dae Won Jun; Jin Hee Park; Yoo Sin Park; Ju-Seop Kang; Eun Kyung Kim; Kyung Tae Kim; Byoung Kwan Son; Seong Hwan Kim; Yun Ju Jo; Young Sook Park
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

7.  Expression patterns of cytokine, growth factor and cell cycle-related genes after partial hepatectomy in rats with thioacetamide-induced cirrhosis.

Authors:  Shu Yang; Chon Kar Leow; Theresa May Chin Tan
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

8.  Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo.

Authors:  Feng Hong; Hsini Chou; Maria Isabel Fiel; Scott L Friedman
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

9.  Partial portal vein ligation plus thioacetamide: a method to obtain a new model of cirrhosis and chronic portal hypertension in the rat.

Authors:  Marta Méndez-López; Magdalena Méndez; Fernando Sánchez-Patán; Isabel Casado; Maria-Angeles Aller; Laudino López; Maria-Teresa Corcuera; Maria-Jose Alonso; Maria-Paz Nava; Jaime Arias; Jorge-Luis Arias
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

10.  Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via αv integrin interaction.

Authors:  Akiko Sugiyama; Keishi Kanno; Norihisa Nishimichi; Shoichiro Ohta; Junya Ono; Simon J Conway; Kenji Izuhara; Yasuyuki Yokosaki; Susumu Tazuma
Journal:  J Gastroenterol       Date:  2016-04-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.